ArticlePediatric surgery international2022
Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model.
Kosuke Kambe et al.PubMed ↗Publisher ↗
No numbers read from the abstract.